As reported by the BBC, a Harvard researcher (Dr Douglas Melton) has succeeded in obtaining philanthropic funding and leading the development of 17 new stem cell lines. These lines will be made available for free to scientists, thus breaking the deadlock over availability of lines caused by US government policies. Dr. Melton and his group deserve widespread commendation and some sort of medal for succeeding in a positive, proactive response to current attacks and legislative limits on stem cell research. Over at Fight Aging!, I explain why the number of available stem cell lines is so important. The bottom line: no stem cell lines means no research, and thus no regenerative medicine to extend the healthy human life span.